Alveolar Macrophage Proteomics in HIV-associated Emphysema

NCT00823927 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 365

Last updated 2021-11-01

No results posted yet for this study

Summary

This study is being done to examine lung function changes in individuals with HIV infection and to understand why individuals with HIV have increased risk of lung damage from cigarette smoking.

Conditions

  • HIV
  • Emphysema
  • HIV Infections

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH
  • Philip Diaz

    lead OTHER

Principal Investigators

  • Philip T Diaz, MD · Ohio State University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-21
Primary Completion
2008-06-23
Completion
2008-06-23

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00823927 on ClinicalTrials.gov